Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Inguinal hernia and Cryptorchidism; and common findings: Ambiguous genitalia, Perineal hypospadias, Tetralogy of Fallot, and Corpus cavernosum hypoplasia and others. 9 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Hormones | 1 | Abnormality of thyroid physiology |
GATA4 encodes GATA binding protein 4 (442 aa). Transcriptional activator that binds to the consensus sequence 5'-AGATAG-3' and plays a key role in cardiac development and function.
Testicular anomalies with or without congenital heart disease is associated with mutations in the GATA4 gene on chromosome 8.
The GATA4 protein participates in Expression of GATA4 in cardiogenesis, Expression of GATA4 in definitive endoderm, and Expression of GATA4 in lateral plate mesoderm pathways.
GATA4 is classified as a druggable target (Clinically Actionable, Enzyme, and Transcription Factor categories) with score 17.4.
Genetic testing for GATA4 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for testicular anomalies with or without congenital heart disease has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 5 common features.
No clinical trials have been registered for testicular anomalies with or without congenital heart disease.
290 publications have been identified in PubMed for testicular anomalies with or without congenital heart disease. Research spans Review / Meta-Analysis (48%), Epidemiology / Natural History (19%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 140 | 48% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 8:35 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Disease patterns and progression |
55 |
19% |
Laboratory research | 38 | 13% |
Patient case studies | 17 | 6% |
Testing and diagnosis research | 16 | 6% |
Other research | 15 | 5% |
New treatment approaches | 5 | 2% |
Clinical study results | 4 | 1% |
Nguyen PT (2026). [PMID: 41992274](https://pubmed.ncbi.nlm.nih.gov/41992274/). *Stem Cell Res Ther*. [Review / Meta-Analysis]
Grabinski Z (2026). [PMID: 41237673](https://pubmed.ncbi.nlm.nih.gov/41237673/). *Am J Emerg Med*. [Review / Meta-Analysis]
Linnane N (2026). [PMID: 42083498](https://pubmed.ncbi.nlm.nih.gov/42083498/). *Curr Opin Cardiol*. [Review / Meta-Analysis]
Gurvitz M (2026). [PMID: 41411480](https://pubmed.ncbi.nlm.nih.gov/41411480/). *J Am Coll Cardiol*. [Review / Meta-Analysis]
Cen R (2026). [PMID: 41307476](https://pubmed.ncbi.nlm.nih.gov/41307476/). *BJOG*. [Basic Science / Preclinical]
Gagliardi MF (2026). [PMID: 42195041](https://pubmed.ncbi.nlm.nih.gov/42195041/). *Genes (Basel)*. [Review / Meta-Analysis]
Peña-Martínez EG (2026). [PMID: 41542063](https://pubmed.ncbi.nlm.nih.gov/41542063/). *Res Sq*. [Basic Science / Preclinical]
Wollborn J (2026). [PMID: 41087256](https://pubmed.ncbi.nlm.nih.gov/41087256/). *J Cardiothorac Vasc Anesth*. [Review / Meta-Analysis]
Arero G (2026). [PMID: 42185024](https://pubmed.ncbi.nlm.nih.gov/42185024/). *Open Heart*. [Review / Meta-Analysis]
Sarubbi B (2026). [PMID: 42183941](https://pubmed.ncbi.nlm.nih.gov/42183941/). *Heart Fail Rev*. [Review / Meta-Analysis]